From May 3rd – 7th, 2024, Dr. Tissana Prasartseree, MD, a Clinical Educator from the Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, presented an oral presentation on the topic “CT- and MRI-based Bone Marrow Dose in CCRT for Cervical Cancer: A Pooled Data from 2 Prospective trials” at The European Society for Radiotherapy and Oncology (ESTRO) 2024 in Glasgow, United Kingdom. Dr. Prasartseree aims to publish this research and establish a new standard in radiotherapy planning for cervical cancer, integrating bone marrow dose constraints.

ESTRO 2024, themed “Radiation Oncology: Bridging the Care Gap”, aims to strengthen radiation oncology’s role as a vital partner in multidisciplinary cancer care. The society’s vision for 2030, “Radiation Oncology. Optimal Health for All, Together”, underscores its commitment to providing accessible, high-value radiation therapy for all cancer patients. The conference will feature Europe’s largest industry exhibition in radiation oncology, offering unparalleled opportunities to engage with industry leaders and explore cutting-edge advancements in technology, techniques, and oncology products.

From May 3rd – 7th, 2024, Mr. Wisawa Phongprapun, a medical physicist from the Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, attended and presented a digital poster on the topic “Cone Beam CT Correction for Preoperative Short Course Radiotherapy for Locally Advanced Rectal Cancer” at “The European Society for Radiotherapy and Oncology (ESTRO) 2024” in Glasgow, United Kingdom.

ESTRO 2024 aims to further reinforce radiation oncology as a core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it, as expressed in the society’s vision statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’ ESTRO 2024 will host Europe’s largest industry exhibition in radiation oncology. It will offer you a unique opportunity to interact with industry leaders and discover the latest developments in technology, techniques, and oncology products.

From May 3rd – 7th, 2024, Miss Sawanya Suwandee, a medical physicist from the Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, attended and presented a digital poster on the topic “Optimal Pressure of CPAP for Reduction Mean Heart Dose in Left-sided Breast Cancer Radiotherapy” at “The European Society for Radiotherapy and Oncology (ESTRO) 2024” in Glasgow, UK.

ESTRO 2024 aims to further reinforce radiation oncology as a core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it, as expressed in the society’s vision statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’ ESTRO 2024 will host Europe’s largest industry exhibition in radiation oncology. It will offer you a unique opportunity to interact with industry leaders and discover the latest developments in technology, techniques, and oncology products.

From May 3rd – 7th, 2024, Doctor Tanun Jitwatcharakomol from the Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, attended and presented a digital poster on the topic “Introduction Non-irradiated Area of Intraoperative Radiotherapy with Electron Technique: Outcomes and Pattern of Failure in Early-Stage Breast Cancer from a Single-Center, Retrospective Registry Study” at “The European Society for Radiotherapy and Oncology (ESTRO) 2024” in Glasgow, UK.

ESTRO’s vision statement ‘Radiation Oncology. Optimal Health for All, Together.’ emphasizes the ambition of ESTRO to further reinforce radiation oncology as a core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it. ESTRO actively focuses on translating science and evidence into practice to support all radiotherapy professionals in their needs for continuous professional development. ESTRO will also increasingly embrace its role in policy through a broadening network of partnerships with all relevant stakeholders.

Duration: July 10th – 12th, 2024

Venue: Srisavarindhira Building
For registration and abstract submission, please visit https://www2.si.mahidol.ac.th/…/event/sm/content/3267/EN/

Date: 10-11 October 2024

Venue: Asia Bangkok Hotel, Bangkok, Thailand

Registration open: 1 May 2024.

For further information and registration, please visit https://www2.si.mahidol.ac.th/sirirajconference/event/sm/content/3248/EN/32475

Ms. Kornrat Pimeaim, Pharm.D, a senior professional pharmacist from the Out-patient Pharmaceutical Care Unit, Out-patient Pharmacy Division, Pharmacy Department Siriraj Hospital, attended “The 9th Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease” in Taipei, Taiwan, from April 26th – 30th, 2024, and presented a poster presentation on the topic “Outcomes of telepharmacy focus on drug-related problems and medication errors in multidrug-resistant tuberculosis patients at the tertiary-care hospital, Thailand”. Pharmacist Pimeaim sought to elevate Siriraj Hospital’s profile within the healthcare community by demonstrating the critical role of pharmacists in interdisciplinary patient care, ultimately contributing to enhanced patient care efficiency.

The 9th Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease aims to share cutting-edge knowledge, promote higher-quality prevention and care, and ultimately eliminate the suffering caused by lung diseases. Held every 2-3 years, the conference brings together eminent, world-class speakers, fosters relationships among Asian countries and beyond, and strengthens international academic cooperation. Moreover, APRC2024 will elevate the global stature of tuberculosis physicians and pulmonologists while providing concrete guidance to shape the future of the pulmonology field. Over 1,500 scholars and experts from around the world were presented with new methods, technologies, and treatments at the conference.

From April 18th – 20th, 2024, Assoc. Prof. Nuttawut Sermsathanasawadi, M.D., Ph.D., from the Division of Vascular Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, attended and presented a research abstract on the topic “Effectiveness of Cyanoacrylate Closure and Compression Compared with Compression Therapy Alone in Healing of Venous Leg Ulcers Caused by Superficial Vein Reflux, a Randomized Controlled Trial” at the “International Vein Congress 2024 (IVC Miami 2024)” in Miami, USA. This congress provided Assoc. Prof. Sermsathanasawadi the opportunity to exchange valuable knowledge with leading international experts in vascular surgery and explore potential collaborations.

In its 22nd year, the IVC continues to be a premier event in the venous field, offering an extraordinary experience for all attendees. The congress features multiple concurrent sessions designed to enhance clinical practice, improve skills, and revolutionize patient care.

From April 13th – 16th, 2024, Assoc. Prof. Pramote Euasobhon, M.D., from the Division of Pain Medicine, Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, was invited as a guest speaker at the “World Congress of Nephrology 2024 (WCN2024)” in Buenos Aires, Argentina, to present on the topic “Non-pharmacologic Management of Pain in Chronic Kidney Disease”. Upon his return, Siriraj Hospital will benefit from his international collaboration with leading experts in the field. The knowledge gained from the conference will be applied to patient care at Siriraj Hospital.

The World Congress of Nephrology (WCN) is the annual scientific, educational, and networking meeting of the International Society of Nephrology. The WCN features regionally-relevant symposia, presentations, training programs, and courses, offering the latest science and state-of-the-art education in nephrology.

From April 5th – 10th, 2024, Assoc. Prof. Adisak Wongkajornsilp, M.D., Ph.D., from the Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, attended The American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, USA, and delivered a poster presentation on the topic “Reversal of dysfunctional CIK cells after the exposure to resistant cholangiocarcinoma cells through chemical perturbation of resistant gene signature.”

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other healthcare professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention to cancer biology, translational, and clinical studies to survivorship and advocacy, the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.